GT
CSTE icon

Glenmede Trust’s Caesarstone CSTE Stock Holding History

Glenmede Trust’s Portfolio CSTE Stock Details CSTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,675
Closed -$563K – 2680
2016
Q4 		$563K Buy
+19,675
New +$625K ﹤0.01% 909

Other funds holding CSTE

BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JC
Joho Capital New York $460M AUM 11.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Glenmede Trust's CSTE Position: Q1 2017 in Review

Glenmede Trust sold out of Caesarstone (CSTE) in Q1 2017, closing a stake of 19,675 shares — an estimated $563K sold.

Glenmede Trust first reported a position in CSTE in Q4 2016 and held it in 1 quarter. The position peaked at $563K in Q4 2016. 132 funds tracked by Wall St. Rank hold CSTE as of Q1 2017.

  • Glenmede Trust reported no remaining Caesarstone position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 19,675 Caesarstone shares in Q1 2017, an estimated $563K.
  • Glenmede Trust first reported a position in Caesarstone in Q4 2016 and held it in 1 quarter.
  • Glenmede Trust's Caesarstone position peaked at $563K in Q4 2016.
  • 132 funds tracked by Wall St. Rank held Caesarstone as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.